Tumor-Specific T-Cells (cCTL:GL01) for Advanced Gastrointestinal Cancer
NCT07735065
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Advanced Gastrointestinal Cancer
Interventions
DRUG:
Biological/Vaccine
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School